NEW: VUMC's Infection Prevention Team recognized for outstanding work

Vanderbilt University Medical Center's Infection Prevention Team is being recognized for their outstanding contributions during this year's battle against the COVID-19 pandemic. View...

UPDATE: COVID-19 VUMC workforce exposure, post-infection, and return-to-work guidelines

Exposure is defined as interactions greater than 10 minutes and closer than 6 feet. Look for any new onset of respiratory or flu-like symptoms, including cough, shortness of breath, loss of smell or taste (without other neurologic symptoms), diarrhea, sore throat, muscle aches, headache, or fever/chills. View...

UPDATE: Exposure, post-infection and return-to-work FAQs

"My spouse/child/roommate/friend/etc. was in contact with someone who was positive. What do I do?" -- and other questions. View...

UPDATE: Weekly COVID-19 statistics

A snapshot of some of the numbers that help tell the story of COVID-19 at Vanderbilt. View...

NEW: Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first "telemedicine" clinical trials to test a potential treatment for COVID-19. View...